Journal of Infection and Chemotherapy Volume 26 Issue 1 to 12

Journal Spotlight: Journal of Infection and Chemotherapy (JIC)

The Journal of Infection and Chemotherapy (JIC) is the official journal of several esteemed Japanese medical societies, including the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Infection Prevention and Control. As a globally inclusive publication, it welcomes a wide range of contributions from the field of chemotherapy and infection management. Here’s an overview of the key areas the journal covers:

Scope of the Journal:

1. Original Research Papers: The journal invites laboratory and clinical research papers from around the world. These papers delve into various aspects of chemotherapy, spanning the pathogenesis, diagnosis, treatment, and control of infections.
2. Case Reports: Clinical insights gained from individual patient cases are of great importance. The journal values case reports as they contribute to the collective understanding of infectious diseases and their management.
3. Notes: Concise research notes that present significant findings or observations are encouraged. These notes can highlight key aspects of infection and chemotherapy.
4. Committee Reports: Reports from committees involved in infection management and chemotherapy provide valuable information for practitioners and researchers in these fields.
5. Surveillance: Information on the surveillance of infectious diseases helps in tracking and responding to outbreaks. These contributions are welcomed.
6. Guidelines: The journal publishes guidelines that offer recommendations for best practices in infection management and chemotherapy.

Focus Areas:

• Antimicrobial Chemotherapy: Research on the use of antimicrobial agents, including antibiotics and antifungals.
• Pathogenesis: Studies that investigate the origins and mechanisms of infectious diseases.
• Diagnosis: Research on the methods and tools for diagnosing infections.
• Epidemiology: Reports on the prevalence and distribution of infectious diseases.
• Clinical Trials: Findings from clinical trials that evaluate new treatments, therapies, or preventive measures.
• Pharmacokinetics: Research on drug absorption, distribution, metabolism, and excretion in the body.
• Animal Models: Experimental studies conducted on animal models to better understand infectious diseases.

International Collaboration: The journal welcomes contributions from across the globe, making it a platform for the exchange of knowledge and best practices in infection management and chemotherapy.

Language: Although the journal has affiliations with Japanese societies, it publishes in English, ensuring broad accessibility and readership.

By promoting research and collaboration in the fields of chemotherapy and infectious disease management, the Journal of Infection and Chemotherapy (JIC) plays a vital role in advancing patient care and public health.

Volume 26, Issue 1: Pages 1-148 (January 2020)

Volume 26, Issue 2: Pages 149-324 (February 2020)

Volume 26, Issue 3: Pages 193-320 (March 2020)

Volume 26, Issue 4: Pages 321-410 (April 2020)

Volume 26, Issue 5: Pages 411-526 (May 2020)

Volume 26, Issue 6: Pages 527-642 (June 2020)

Volume 26, Issue 7: Pages 643-774 (July 2020)

Volume 26, Issue 8: Pages 775-872 (August 2020)

Volume 26, Issue 9: Pages 873-1014 (September 2020)

Volume 26, Issue 10: Pages 1015-1110 (October 2020)

Volume 26, Issue 11: Pages 1111-1236 (November 2020)

Volume 26, Issue 12: Pages 1237-1344 (December 2020)